Wednesday, 18 Jul 2018

You are here

The RheumNow Week in Review - 8 December 2017

Dr. Jack Cush covers the news and journal articles published on RheumNow.comin the past week.

  1. Systematic review of ULT discontinuation - 5 studies shows that ULT D/C has good short term outcomes (esp if SUA is low) but delayed relapse rates occcuring 1-4.5 yrs later - more in gout (36-81%), less w/ urolithiasis (15%). https://t.co/RTIwuH154S
  2. Prospective study of 133 IBD pts (64% CD, 36% UC) switched from Remicade to biosimilar Inflectra. After 12 mos. no differences in drug levels, disease activity between innovator and biosimilar. https://t.co/QEH3lUaXD4
  3. FDA grants orphan drug designation to SER-287 a microbiome drug to treat dysbiosis of pediatric ulcerative colitis. Will microbiome targeted therapies be the next (safe) best thing? https://t.co/PmOLeyLyy3     
  4. Patients with autoimmune connective tissue diseases (CTDs) undergoing abdominoplasty are at higher risk for certain complications (hematomas, venous thromboembolism, need for transfustions and longer hospital stays) https://t.co/AXLKNg0ag2
  5. Coffee consumption (3-4cups/day) assoc w/ 17% reduction in all cause mortality, 19% for CV mortality, 18% lower Cancer risk; but in pregnancy, high versus low/no consumption was associated with 30% increase in low birth weight and pregnancy loss (OR 1.46). https://buff.ly/2iNa7M0
  6. TWO simple tests to diagnose #Fibromyalgia in primary care: 1) for tenderness to digital pressure at 10 body sites; 2)  single question, “I have a persistent deepaching over most of my body” (0–10)  https://buff.ly/2iIx03s
  7. 2005-20014 - prevalence of one comorbidity assoc w/ pregnancy & delivery increased 50% (66.9 to 91.8 per 1,000 delivery hosp.) in the USA. The frequency of multiple chronic conditions doubled ( 4.7 to 8.1/1000 delivery) during this sameperiod. https://buff.ly/2iNuDMx
  8. Infliximab Does Not Increase Perioperative Infection 
  9. Ixekizumab (Taltz) FDA Approved for Psoriatic Arthritis 
  10. Do JAK Inhibitors Increase the Risk of Venous Thromboembolic Events? 
  11. Why TNF Inhibitors May Work in Some Autoinflammatory Patients 

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

Proposed Changes for 2019 Medicare Fee Schedule

On July 12th the Centers for Medicare & Medicaid Services (CMS) released its proposed rule changes for the 2019 Medicare physician fee schedule.  This year, CMS has combined the Medicare physician fee schedule proposed rule with recommendations for the Quality Payment Program (QPP), which will be officially published in the Federal Register on July 27.

Trend Towards Fewer Self-Employed Physicians

 

A nationwide survey study analyzed healthcare provider (HCP) employment type (self-employed, employed by private sector, or employed by government) and annual labor earnings (2001 to 2015) and found that the health care landscape is changing with few self-employed practitioners and more being larger organizations. 

The RheumNow Week in Review –Fateful Outcomes in Rheumatology (7.13.18)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  Fateful outcomes in Rheumatology, what happens to Seronegatives, IL-23 fails, MRI progression, Not all inflammatory back pain becomes SpA:

The RheumNow Week in Review – Life Savers for Rheumatologists (6.29.18)

Dr. Jack Cush reviews selected news and journal reports from the past week on RheumNow.com.

The RheumNow Week in Review – EULAR18 Epilogue (6.22.18)

Dr. Jack Cush reviews EULAR 2018 and the past week's news and reports from RheumNow.com, including DMARDs in OA, the price of Penicillamine, Infections when ANCA+, CV outcomes in gout, NSAIDs in Pregnancy and Seropostive vs. Seronegative Outcomes.